Literature DB >> 15887625

Microalbuminuria, brain vasomotor reactivity, carotid and kidney arterial flow in Type 2 diabetes mellitus.

F Gregorio1, F Ambrosi, F Carle, M Boemi, M Boscaro, M G Ceravolo, L Evangelisti, E Bordoni, C Sardu.   

Abstract

Diabetic microangiopathy produces widespread small vessel impairment which particularly affects renal glomeruli functions. Microalbuminuria is the earliest marker of microangiopathic kidney disease and has also recently been recognised as a marker of macroangiopathic cardiovascular involvement. To determine correlations between daily microalbuminuria, local microangiopathic kidney damage, systemic macroangiopathic involvement and functional brain microcirculation, 70 Type 2 diabetic subjects who were diagnosed more than 5 years ago underwent carotid (to determine index of macro- and microangiopathy) and interlobar kidney artery color Doppler (to determine microangiopathic involvement), transcranial Doppler (to determine alterations in brain vasomotor reserve), and evaluation of daily albumin excretion rate. All the indices of microcirculatory involvement in the kidney, brain and small vessels downstream-from the carotid arteries were closely related (for all p<0.001) but never correlated with the macroangiopathy index. Daily microalbuminuria correlated with all the micro- (p<0.0001) and macroangiopathic (p<0.005) Doppler indices. These findings confirm that microangiopathy is the main cause of the diabetic increase in the albumin excretion rate and support the view that microalbuminuria can be considered a powerful biomarker of widespread macroangiopathy. Our results suggest microalbuminuria may also identify cerebrovascular diabetic involvement, as it predicts both macroangiopathic carotid alteration and microvascular brain impairment.

Entities:  

Mesh:

Year:  2004        PMID: 15887625

Source DB:  PubMed          Journal:  Diabetes Nutr Metab        ISSN: 0394-3402


  4 in total

1.  Cerebrovascular reactivity, intima-media thickness, and nephropathy presence in patients with type 1 diabetes.

Authors:  Grzegorz M Kozera; Bogumił Wolnik; Katarzyna B Kunicka; Sebastian Szczyrba; Joanna Wojczal; Ulf Schminke; Walenty M Nyka; Leszek Bieniaszewski
Journal:  Diabetes Care       Date:  2009-02-19       Impact factor: 17.152

2.  Urinary albumin to creatinine ratio as potential biomarker for cerebral microvascular disease.

Authors:  Amanda L Strickland; Heidi C Rossetti; Ronald M Peshock; Myron F Weiner; Paul A Nakonezny; Roderick W McColl; Keith M Hulsey; Sandeep R Das; Kevin S King
Journal:  Curr Neurovasc Res       Date:  2014       Impact factor: 1.990

3.  Cerebrovascular reactivity is impaired in patients with non-insulin-dependent diabetes mellitus and microangiopathy.

Authors:  Ligia Petrica; Maxim Petrica; Adrian Vlad; Flaviu Bob; Cristina Gluhovschi; Gheorghe Gluhovschi; Catalin D Jianu; Sorin Ursoniu; Adalbert Schiller; Silvia Velciov; Virginia Trandafirescu; Gheorghe Bozdog
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

4.  A Network Pharmacology Approach to Uncover the Mechanisms of Shen-Qi-Di-Huang Decoction against Diabetic Nephropathy.

Authors:  Sha Di; Lin Han; Qing Wang; Xinkui Liu; Yingying Yang; Fan Li; Linhua Zhao; Xiaolin Tong
Journal:  Evid Based Complement Alternat Med       Date:  2018-11-01       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.